Researchers, including Carl June of the Perelman School of Medicine, are mentioned for getting approval for the first human use of the gene-editing technology CRISPR to help target three types of cancer.
https://www.washingtonpost.com/news/to-your-health/wp/2016/06/21/federal-panel-approves-first-test-of-crispr-editing-in-humans/ The Washington Post